Evaluation of an Herbal Extract on Sleep Parameters

January 29, 2025 updated by: Aventure AB

Evaluation of an Herbal Extract on Sleep Parameters in Healthy, Middle-aged Women

The overall purpose of this interventional study is to investigate how a specific herbal extract influences the quality of sleep in middle-aged women with mild to moderate insomnia. During the study, the participants are asked to take the test drink every night for two weeks. Both objective (Oura ring) and subjective (analog sleep diaries, questionnaires) measures are included to evaluate sleep parameters as well as perceived alertness and impact on daily functions. The primary outcome is sleep onset latency (SOL), which is the time it takes for a person to fall asleep. Secondary outcomes which will be evaluated include time spent in different sleep stages, number of times waking up during the night, and various qualitative ratings of energy levels and mood during the day.

Researchers will compare the group with active product and placebo product to see if the consumption of the herbal extract will lead to improvements in the factors mentioned above.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lund, Sweden
        • Aventure Clinical Trial Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Female
  • Age 35-60
  • BMI 18-30 kg/m2
  • Mild to moderate insomnia according to the ISI (Insomnia Severity Index) questionnaire (ISI-value 10-21)
  • Matching results from the Oura ring and sleep diaries during the run-in period

Exclusion Criteria:

  • Metabolic disease (diabetes, cardiovascular disorders, hypo- or hyperthyroidism, etc)
  • Severe psychiatric disorders
  • Pregnancy, breastfeeding
  • Restless legs or leg cramps that influence sleep and everyday life
  • Conditions that prevent sleep through the symptoms that they produce (pain, nightly coughs, etc)
  • Breathing problems (asthma, severe snoring, sleep apnea, etc)
  • Medication that can influence sleep and/or wakefulness
  • Consumption of herbal sedatives during the last month
  • Having someone in the household that needs to be tended to during the night and pose a major risk to disturb the research participant's sleep to a large extent.
  • Irregular work hours, including shift work at night
  • Regularly sleeping more than 1 night per week away from home
  • Tobacco or drug use
  • Other factors that are deemed to influence participation negatively

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Active product
The active product is a drink consisting of 600 mg of lemon balm extract, tea leaves, brown sugar and powdered flavoring agent that is mixed with lukewarm water. The volume per serving is 30 ml. The drink will be taken every night before sleep for a period of two weeks.
30 ml drink containing 600 mg of lemon balm extract, tea leaves, brown sugar and flavoring agent, two weeks daily
Placebo Comparator: Placebo
The placebo drink is maltodextrin mixed with water, and the same tea leaves, brown sugar and powdered flavoring agent as the test drink. The volume per serving is 30 ml. The drink will be taken every night before sleep for a period of two weeks.
30 ml placebo drink containing maltodextrin, tea leaves, brown sugar and flavoring agent, two weeks daily

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep onset latency
Time Frame: 2 weeks
The length of time it takes a person to fall asleep when turning the lights off, this parameter will be measured by using the Oura Ring
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time spent in different sleep stages
Time Frame: 2 weeks
These Parameters will be measured by using the Oura Ring
2 weeks
Perceived alertness and wellbeing during the day
Time Frame: 2 weeks
These parameters will be measured by using a sleep diary (pen and paper) with a ranking scale which needs to be filled out in the morning and in the evening
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2023

Primary Completion (Actual)

June 19, 2024

Study Completion (Actual)

June 24, 2024

Study Registration Dates

First Submitted

March 29, 2023

First Submitted That Met QC Criteria

April 13, 2023

First Posted (Actual)

April 26, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 29, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Sleepwell_2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Onset Latency

Clinical Trials on Herbal extract drink

Subscribe